Developing survival prediction models in colorectal cancer using epigenome-wide DNA methylation data from whole blood.
Saved in:
| Title: | Developing survival prediction models in colorectal cancer using epigenome-wide DNA methylation data from whole blood. |
|---|---|
| Authors: | Fan Z; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany., Edelmann D; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Yuan T; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany., Köhler BC; Liver Cancer Center Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Hoffmeister M; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany., Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. h.brenner@Dkfz-Heidelberg.de.; NCT Heidelberg, National Center for Tumor Diseases (NCT) a partnership between DKFZ and University Hospital, Heidelberg, Germany. h.brenner@Dkfz-Heidelberg.de.; Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany. h.brenner@Dkfz-Heidelberg.de.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. h.brenner@Dkfz-Heidelberg.de. |
| Source: | NPJ precision oncology [NPJ Precis Oncol] 2024 Sep 06; Vol. 8 (1), pp. 191. Date of Electronic Publication: 2024 Sep 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
